...
机译:患者报告的随机,主动控制,开放标签,Burosumab对X-联合次磷血症儿童的常规治疗的试验
Royal Manchester Childrens Hosp Dept Paediat Endocrinol Manchester Lancs England;
Washington Univ Shriners Hosp Children Sch Med St Louis MO USA;
McGill Univ Shriners Hosp Children Montreal PQ Canada;
Univ Sydney Childrens Hosp Westmead Sch Clin Westmead NSW Australia;
Univ Ottawa Dept Pediat Ottawa ON Canada;
Karolinska Inst Div Pediat Endocrinol Stockholm Sweden;
Univ Calif San Francisco Dept Pediat San Francisco CA USA;
Vanderbilt Univ Sch Med Div Endocrinol &
Diabet Dept Pediat Nashville TN 37212 USA;
Japan Community Healthcare Org Osaka Hosp Dept Pediat Osaka Japan;
Seoul Natl Univ Childrens Hosp Seoul South Korea;
Childrens Hosp Los Angeles Ctr Endocrinol Diabet &
Metab Los Angeles CA 90027 USA;
Hosp Sick Children Dept Paediat Toronto ON Canada;
Johannes Kepler Univ Linz Dept Paediat &
Adolescent Med Linz Austria;
Kanagawa Childrens Med Ctr Dept Endocrinol &
Metab Yokohama Kanagawa Japan;
Okayama Saiseikai Gen Hosp Outpatient Ctr Okayama Japan;
Shriners Hosp Children St Louis MO USA;
Univ Sydney Childrens Hosp Westmead Sch Clin Westmead NSW Australia;
Univ Calif San Francisco Dept Pediat San Francisco CA USA;
Kyowa Kirin Int Marlow Bucks England;
Chilli Consultancy Salisbury Wilts England;
Kyowa Kirin Pharmaceut Dev Princeton NJ USA;
Ultragenyx Pharmaceut Novato CA USA;
Ultragenyx Pharmaceut Novato CA USA;
Indiana Univ Sch Med Dept Med Indianapolis IN 46202 USA;
Burosumab; X-linked hypophosphatemia; Patient-reported outcomes; Patient-reported outcomes measurement information system;
机译:Burosumab对X型脾脏患儿的常规治疗患儿:随机,主动控制,开放标签,第3阶段试验(Vol 393,PG 2416,2019)
机译:Burosumab与X型次次次磷血症儿童的常规治疗:随机,主动控制,开放标签,第3阶段试验
机译:来自第3期的长期患者报告的常规前瞻性试验对局部前列腺癌的常规相反的次要辐射治疗
机译:各种方案在轻度至中度哮喘儿童中维持抗炎治疗方案的有效性:前瞻性多中心随机试验的结果
机译:白茅根和枸杞子汤治疗儿童持续性无症状孤立性血尿的效果:探索性随机,开放标签,对照试验
机译:患者报告的Palbociclib加仑的结果与GNRH激动剂与激素受体阳性转移性乳腺癌的前进妇女在前肢患者中的葡萄酒丛(KCSG-BR 15-10)
机译:患者报告的来自随机,主动控制的开放标签,Burosumab对X链磷血症儿童的常规治疗的阶段3试验
机译:增强OIF / OEF返回者的创伤后应激障碍结果:延长暴露治疗的氢化可的松增强的随机临床试验